DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Topical Treatment of Under Eye Dark Circles and Swelling

Information source: The Connecticut Sinus Center, PC
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Edema

Intervention: Fexofenadine (Drug); Placebo (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: The Connecticut Sinus Center, PC

Official(s) and/or principal investigator(s):
Edward M Lane, MD, Study Director, Affiliation: The Connecticut Sinus Center, PC

Summary

This study examines topical treatment of under eye circles and swelling.

Clinical Details

Official title: A Pilot Randomized Double Blind Study to Assess the Safety and Efficacy of 1% Ibuprofen/ 1%Fexofenadine Topical Cream for the Treatment of Dark Circles Under the Eyes

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention

Detailed description: This study examines topical treatment of under eyes dark circles and under eye swelling.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Under eye dark circles and swelling

Exclusion Criteria:

- Under age 18

- Allergy to tested medicines

Locations and Contacts

TKL Research, Paramus, New Jersey 07652, United States
Additional Information

Starting date: September 2010
Last updated: February 16, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017